Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Glycerol phenylbutyrate
Drug ID BADD_D01032
Description Glycerol phenylbutyrate is a nitrogen-binding agent. Chemically, it is a triglyceride in which three molecules of phenylbutyrate are linked to a glycerol backbone. FDA approved on February 1, 2013.
Indications and Usage Glycerol phenylbutyrate is a nitrogen-binding agent for the chronic management of adult and pediatric patients ≥2 years of age with urea cycle disorders (UCDs) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.
Marketing Status Prescription
ATC Code A16AX09
DrugBank ID DB08909
KEGG ID D10127
MeSH ID C570223
PubChem ID 10482134
TTD Drug ID D0E0BD
NDC Product Code 58159-034; 75987-050; 65977-0121; 67262-0009; 14501-0097; 67262-0008; 45941-3054
Synonyms glycerol phenylbutyrate | HPN 100 | HPN100 | HPN-100 | Ravicti
Chemical Information
Molecular Formula C33H38O6
CAS Registry Number 611168-24-2
SMILES C1=CC=C(C=C1)CCCC(=O)OCC(COC(=O)CCCC2=CC=CC=C2)OC(=O)CCCC3=CC=CC=C3
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal pain07.01.05.005--
Gout14.09.01.001; 15.01.06.0010.021361%Not Available
Headache17.14.01.0010.138846%
Hyperammonaemia14.10.01.001; 09.01.02.0020.341775%Not Available
Hypertension24.08.02.0010.021361%
Hypokalaemia14.05.03.0020.021361%
Hyponatraemia14.05.04.0020.032041%
Influenza22.07.02.001; 11.05.03.0010.005572%Not Available
Irritability19.04.02.013; 08.01.03.0110.117485%
Laboratory test abnormal13.18.01.0010.021361%Not Available
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.0080.074763%
Liver function test abnormal13.03.01.0130.021361%Not Available
Malaise08.01.01.003--
Menstruation irregular21.01.01.005; 05.05.01.0080.021361%
Mental impairment19.21.02.003; 17.03.03.0020.021361%Not Available
Metabolic acidosis14.01.01.0030.074763%Not Available
Migraine24.03.05.003; 17.14.02.0010.032041%Not Available
Mood altered19.04.02.0070.021361%Not Available
Nasal congestion22.04.04.0010.021361%
Nasopharyngitis22.07.03.002; 11.01.13.0020.042722%Not Available
Nausea07.01.07.0010.117485%
Nervous system disorder17.02.10.001--Not Available
Pallor24.03.04.001; 23.03.03.031; 08.01.03.0320.021361%Not Available
Palpitations02.01.02.0030.021361%
Pancreatitis07.18.01.0010.021361%
Pneumonia11.01.09.003; 22.07.01.003--Not Available
Premature labour18.07.01.0020.021361%Not Available
Pyrexia08.05.02.0030.085444%
Rash23.03.13.001--Not Available
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages